News from our Infection Department
Together with our colleagues from Amsterdam and Leiden, we have taken a closer look into the antiinfective and immunomodulating effects our in-house […]
Category: Science
Publication Highlight: Novel JAK3 Inhibitor
One of our premier internal research projects involves the development of novel, selective inhibitors of Janus kinase 3, a compound class of […]
Latest Publications
It has been a successful year so far for our scientists in the Synovo labs with a number of publications. We are […]
One step closer
After an intense ECCMID in Madrid, surrounded by the world top initiatives in the topic of infectious diseases, we are more and […]
Our anti-microbial program has been funded
We announce funding for our breakthrough anti-microbial research program by the Netherlands NACTAR program from the Netherlands organization for Scientific Research (NWO). […]
Study 1000!!
Thanks to those who believe in us and let us participate in the development of their products by providing pharmacology services. We […]
Synovo and ophthalmology
We expand business to ophthalmologyTübingen, Germany, February 2014. Synovo, a company focused on drug discovery and preclinical development, today announced the strategic […]